Dr. Reddy's Semaglutide DINs Received, Approval Pending

Dr. Reddy's clarifies a news article, confirming it received Drug Identification Numbers (DINs) for Semaglutide Injection from Health Canada on April 22, 2026.
The company states it has not yet received the final 'Notice of Compliance' approval for the product from Health Canada.
This disclosure was made proactively to the stock exchanges in response to a price movement and a query from the NSE (Ref: NSE/CM/Surveillance/16905).
The company asserts there is no undisclosed material information and no material impact from the news article.